ScholarIQanswers from OpenAlex & ORCID
Bengt Fellström
ResearcherPublications, citations & collaboration network
Bengt Fellström is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Bengt Fellström have?
ScholarIQindexed works
Bengt Fellström has 351 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bengt Fellström have?
ScholarIQcitation count
Bengt Fellström has 18,361 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Bengt Fellström?
ScholarIQh-index
Bengt Fellström has an h-index of 65 in OpenAlex.
What is the i10-index of Bengt Fellström?
ScholarIQi10-index
Bengt Fellström has an i10-index of 181 in OpenAlex.
What is the ORCID of Bengt Fellström?
ScholarIQorcid
The ORCID for Bengt Fellström is on the source record.
What is the OpenAlex record for Bengt Fellström?
ScholarIQopenalex
The OpenAlex for Bengt Fellström is on the source record.
What are the most-cited papers on Bengt Fellström?
ScholarIQmost cited works
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent, Martin Landray, Christina Reith, Jonathan Emberson, David C. Wheeler, Charles Tomson, Christoph Wanner, Vera Krane, Alan Cass, Jonathan C. Craig, Bruce Neal, Lixin Jiang, Lai Seong Hooi, Adeera Levin, Lawrence Y. Agodoa, Mike Gaziano, Bertram L. Kasiske, Robert Walker, Ziad A. Massy, Bo Feldt‐Rasmussen, Udom Krairittichai, Vuddidhej Ophascharoensuk, Bengt Fellström, Hallvard Holdaas, Vladimı́r Tesař, Andrzej Więcek, Diederick E. Grobbee, Dick de Zeeuw, Carola Grönhagen‐Riska, Tanaji Dasgupta, David Lewis, William G. Herrington, Marion Mafham, William Majoni, Karl Wallendszus, Richard H. Grimm, Terje Pedersen, Jonathan A. Tobert, Jane Armitage, Alex Baxter, Christopher Bray, Yiping Chen, Zhengming Chen, Michael Hill, Carol Knott, Sarah Parish, David Simpson, Peter Sleight, Alan Young, Rory Collins
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt Fellström, Alan G. Jardine, Roland E. Schmieder, Hallvard Holdaas, Kym M. Bannister, Jaap J. Beutler, Dong‐Wan Chae, Alejandro Chevaile, Stuart M. Cobbe, Carola Grönhagen‐Riska, José J. De Lima, R. Lins, Gert Mayer, Alan W. McMahon, Hans‐Henrik Parving, Giuseppe Remuzzi, Ola Samuelsson, S. Sonkodi, Gültekin Süleymanlar, Dimitrios Tsakiris, Vladimı́r Tesař, Vasil Todorov, Andrzej Więcek, Rudolf P. Wüthrich, Mattis Gottlow, Eva Johnsson, Faı̈ez Zannad
Diagnostic Utility of Exome Sequencing for Kidney Disease
Emily Groopman, Maddalena Marasà, Sophia Cameron‐Christie, Slavé Petrovski, Vimla S. Aggarwal, Hila Milo Rasouly, Yifu Li, Junying Zhang, Jordan G. Nestor, Priya Krithivasan, Wan Yee Lam, Adele Mitrotti, Stacy Piva, Byum Hee Kil, Debanjana Chatterjee, Rachel Reingold, Drew Bradbury, Michael DiVecchia, Holly Snyder, Xueru Mu, Karla Mehl, Olivia Balderes, David Fasel, Chunhua Weng, Jai Radhakrishnan, Pietro A. Canetta, Gerald B. Appel, Andrew S. Bomback, Wooin Ahn, Natalie Uy, Shumyle Alam, David J. Cohen, Russell J. Crew, Geoffrey K. Dube, Maya K. Rao, Sitharthan Kamalakaran, Brett Copeland, Zhong Ren, Joshua Bridgers, Colin D. Malone, Caroline M. Mebane, Neha Dagaonkar, Bengt Fellström, Carolina Haefliger, Sumit Mohan, Simone Sanna‐Cherchi, Krzysztof Kiryluk, Jan Fleckner, Ruth March, Adam Platt, David B. Goldstein, Ali G. Gharavi
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
Bengt Fellström, Jonathan Barratt, H. Terence Cook, Rosanna Coppo, John Feehally, Johan W. de Fijter, Jürgen Floege, Gerd R. Hetzel, Alan G. Jardine, Francesco Locatelli, Bart Maes, Alex Mercer, Fernanda Ortiz, Manuel Praga, Søren Schwartz Sørensen, Vladimı́r Tesař, Lucia Del Vecchio